Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Freegold Intersects 3.62 g/t Au over 42m and 1.23 g/t Au over 170.7m (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Zivo Bioscience Inc ZIVO

Consumer Defensive Household & Personal Products
Zivo Bioscience, Inc. is a research and development company. The Company operates in both the biotech and agtech sectors, with an intellectual property portfolio comprised of algal and bacterial strains, biologically active molecules and complexes, production techniques, cultivation techniques and patented or patent-pending inventions for applications in human and animal health. Its product... see more

Recent & Breaking News (OTCQB:ZIVO)

Zivo Bioscience, Inc. to Participate in the Global AgTech Virtual Conference Presented by Maxim Group LLC and hosted by M-Vest on October 14, 2021 at 10 A.M. EDT

GlobeNewswire October 6, 2021

Weblink Instructions for the Annual Meeting of Shareholders of Zivo Bioscience, Inc.

GlobeNewswire October 5, 2021

Zivo Bioscience, Inc. Issues Letter to Shareholders

GlobeNewswire August 17, 2021

Zivo Bioscience to Present at Two Upcoming August Conferences

GlobeNewswire August 11, 2021

ZIVO Bioscience to Present at the Q3 Virtual Investor Summit

Newsfile August 11, 2021

Zivo Bioscience, Inc. Announces Closing of Underwriters' Partial Exercise of Over-Allotment Option in Connection with its Previously Announced Public Offering

GlobeNewswire July 2, 2021

ZIVO Bioscience to Present at the LD Micro Virtual Invitational Conference on June 9, 2021

GlobeNewswire June 2, 2021

Zivo Bioscience, Inc. Announces Closing of Upsized $13.8 Million Public Offering and Uplisting to Nasdaq

GlobeNewswire June 2, 2021

Zivo Bioscience, Inc. Announces Pricing of Upsized $13.8 Million Public Offering and Up-listing to Nasdaq

GlobeNewswire May 27, 2021

ZIVO Bioscience Announces US Patent Office Notice of Allowance for Administration of Proprietary Algal Biomass to Support Immune Health

GlobeNewswire April 26, 2021

ZIVO Bioscience to Participate in Maxim Group's Inaugural Emerging Growth Virtual Conference

GlobeNewswire March 11, 2021

ZIVO Bioscience Successfully Confirms Poultry Growth Promotion and Feed Conversion Ratio Improvements in Typical Production Environments

Accesswire January 11, 2021

Zivo Bioscience Names Keith R. Marchiando as Chief Financial Officer

Accesswire January 7, 2021

Zivo Bioscience Releases Positive Results From Recent Poultry Trial

Accesswire July 13, 2020

ZIVO Bioscience Receives Notice of Allowance for Cytokine Modulation Patent Application From US Patent Office, Commences Bioproduct Scaleup

Accesswire June 9, 2020

ZIVO Bioscience Appoints Industry Veterans To Join Senior Management Team

Accesswire March 30, 2020

ZIVO Bioscience Announces Impressive Long-Term Benefits for Broiler Poultry Nutrition and Growth Promotion

Accesswire March 18, 2020

ZIVO Bioscience Announces Impressive Results for Poultry Gut Health Studies Conducted in Q3/Q4 2019 Utilizing Proprietary Algal Biomass as Feed Ingredient

Accesswire February 6, 2020

Zivo Bioscience Announces Patent Filings for a Novel, Proprietary, Immune-Modulating/Anti-Inflammatory Molecular Complex

Accesswire December 18, 2019

Wellmetrix and DSM Announce Research Partnership to Assess Diagnostic Platform for Personalized Nutrition

Accesswire October 8, 2019